Clearstead Advisors, LLC Abbott Laboratories Transaction History

Clearstead Advisors, LLC

$6.31 Billion
Q3 2024

A detailed history of Clearstead Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Clearstead Advisors, LLC holds 129,105 shares of ABT stock, worth $14.8 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

129,105

Previous 131,774 2.03%

Holding current value

$14.8 Million

Previous $13.7 Million 7.5%

% of portfolio

0.23%

Previous 0.24%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $267,086 - $315,288	-2,669 Reduced 2.03%	129,105 $14.7 Million
Q2 2024 Aug 09, 2024	BUY	$100.73 - $112.44 $4.18 Million - $4.66 Million	41,455 Added 45.9%	131,774 $13.7 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $343,564 - $379,451	-3,137 Reduced 3.36%	90,319 $10.3 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $22,727 - $27,820	-252 Reduced 0.27%	93,456 $10.3 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $478,318 - $573,902	-5,007 Reduced 5.07%	93,708 $9.08 Million
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $475,643 - $570,692	4,979 Added 5.31%	98,715 $9.56 Million
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $427,105 - $475,885	4,238 Added 4.74%	93,736 $10.2 Million
Q1 2023 May 09, 2023	BUY	$96.86 - $114.01 $114,197 - $134,417	1,179 Added 1.33%	89,498 $9.06 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $27,472 - $32,229	289 Added 0.33%	88,319 $9.7 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $244,028 - $282,539	-2,522 Reduced 2.79%	88,030 $8.52 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $83,187 - $100,546	815 Added 0.91%	90,552 $9.84 Million
Q1 2022 May 04, 2022	BUY	$114.02 - $139.04 $18,129 - $22,107	159 Added 0.18%	89,737 $10.6 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $265,603 - $325,216	2,299 Added 2.63%	89,578 $12.6 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $276,017 - $305,355	-2,366 Reduced 2.64%	87,279 $10.3 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $163,445 - $192,398	1,545 Added 1.75%	89,645 $10.4 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $554,648 - $653,460	5,096 Added 6.14%	88,100 $10.6 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $249,480 - $271,861	2,376 Added 2.95%	83,004 $9.09 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $404,865 - $491,679	-4,418 Reduced 5.19%	80,628 $8.78 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $703,525 - $900,424	9,188 Added 12.11%	85,046 $7.78 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $188,836 - $276,131	-3,006 Reduced 3.81%	75,858 $5.99 Million
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $97,195 - $108,201	1,238 Added 1.59%	78,864 $6.85 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $309,928 - $336,058	-3,787 Reduced 4.65%	77,626 $6.5 Million
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $7,871 - $9,180	108 Added 0.13%	81,413 $6.85 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $178,065 - $215,281	-2,689 Reduced 3.2%	81,305 $6.5 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $162,195 - $183,743	-2,474 Reduced 2.86%	83,994 $6.08 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $95,410 - $115,101	-1,569 Reduced 1.78%	86,468 $6.34 Million
Q2 2018 Aug 07, 2018	BUY	$57.57 - $63.54 $158,893 - $175,370	2,760 Added 3.24%	88,037 $5.37 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $124,300 - $140,536	-2,209 Reduced 2.52%	85,277 $5.11 Million
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $96,462 - $103,273	-1,797 Reduced 2.01%	87,486 $4.99 Million
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $4.29 Million - $4.79 Million	89,283	89,283 $4.76 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Account

Clearstead Advisors, LLC Abbott Laboratories Transaction History